EvoEndo® Announces Key Leadership Transitions
Retrieved on:
Thursday, April 6, 2023
Health Technology, Health, Surgery, Medical Devices, Marketing, Boston Scientific, Elective surgery, TNE, Health administration, Laparoscopy, MBA, State University of New York at New Paltz, Endoscopy, Doctor of Philosophy, The New School, St. Lawrence University, Regeneration, Hospital, Traction, GM, Patient, Standard of care, Physician, Harvard Business School, MEMS, Growth, FDA, Management
EvoEndo®, Inc. (“EvoEndo” or the “Company”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), today announced key leadership changes.
Key Points:
- EvoEndo®, Inc. (“EvoEndo” or the “Company”), a medical device company developing platforms for Unsedated Transnasal Endoscopy (TNE), today announced key leadership changes.
- Mr. Jonathan T. Hartmann brings over 25 years of leadership experience in growing new health technology markets.
- Mr. Hartman spent 20 years at Boston Scientific, holding several senior leadership positions in the endoscopy division, including VP of Marketing.
- “I am excited to join the leadership team alongside Jonathan,” stated Ryan.